
Alert: New Earnings Report (5/9/24)-Collegium Pharmaceutical Inc (NASDAQ: COLL).
Collegium Pharmaceutical Inc (NASDAQ: COLL) has reported earnings for its first fiscal quarter (ending March 31) of $0.86 versus a loss $-0.51 for the same period a year ago. Relative to the consensus estimate of […]